These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 300489)

  • 1. Influence of freezing and storage methods on concentrations of brain DOPA and 5 HTP after pretreatment with a decarboxylase inhibitor.
    McNamara MC; Miller AT; Davis JN
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):569-72. PubMed ID: 300489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain and peripheral metabolism of 5-hydroxytryptophan-14C following peripheral decarboxylase inhibition.
    Warsh JJ; Stancer HC
    J Pharmacol Exp Ther; 1976 Jun; 197(3):545-55. PubMed ID: 1084420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and simple analysis of DOPA and 5-HTP using high performance liquid chromatography with electrochemical detection.
    Arnerić SP; Goodale DB; Flynn JR; Long JP
    Brain Res Bull; 1981 May; 6(5):407-11. PubMed ID: 6454458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origin of 5-hydroxytryptophan and l-dopa accumulating in brain following decarboxylase inhibition.
    Bédard P; Carlsson A; Fuxe K; Lindqvist M
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(1):1-6. PubMed ID: 4252440
    [No Abstract]   [Full Text] [Related]  

  • 5. Attempts to measure endogenous levels of dopa and 5-hydroxytryptophan in rat brain.
    Lindqvist M; Kehr W; Carlsson A
    J Neural Transm; 1975; 36(3-4):161-76. PubMed ID: 1080799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turnover of central biogenic amines in one-kidney, one-clip renal hypertensive rats.
    Shum AY; Chen CS; Hsu SC; Chen CF
    Neurosci Lett; 1987 Mar; 75(2):223-8. PubMed ID: 3106860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical and ecological considerations of L-dopa and 5-HTP in seeds.
    Bell EA; Janzen DH
    Nature; 1971 Jan; 229(5280):136-7. PubMed ID: 4923106
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of DOPA accumulation by rat brain at critical L-DOPA circulating concentrations.
    Horst WD; Bautz G; Renyi E; Spirt N
    Adv Neurol; 1974; 5():369-73. PubMed ID: 4440584
    [No Abstract]   [Full Text] [Related]  

  • 9. The proportionate loss of L-3,4-dihydroxyphenylalanine and L-5-hydroxttryptophan decarboxylating activity in rat central nervous system following intracisternal administration of 5, 6-dihydroxytryptamine or 6-hydroxydopamine.
    Dairman W; Horst WD; Marchelle ME; Bautz G
    J Neurochem; 1975 Apr; 24(4):619-23. PubMed ID: 1079044
    [No Abstract]   [Full Text] [Related]  

  • 10. Time and dose influences on the behavioral effects of L-DOPA and 5-hydroxytryptophan after inhibition of extracerebral decarboxylase.
    Gronan RJ
    Pharmacol Biochem Behav; 1975; 3(2):161-6. PubMed ID: 1079949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of 5-hydroxytryptophan and 3,4-dihydroxyphenylalanine in rat brain by HPLC with electrochemical detection following electrical stimulation of the dorsal raphe nucleus.
    Duda NJ; Moore KE
    J Neurochem; 1985 Jan; 44(1):128-33. PubMed ID: 3917287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ freezing of the rabbit and rat brain.
    Roos MW; Johansson A; Sperber GO
    Cryobiology; 1997 Sep; 35(2):187-91. PubMed ID: 9299110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central 5-HTP decarboxylase inhibiting properties of Ro 4-4602 in relation to 5-HTP potentiation in mice.
    Hyttel J; Fjalland B
    Eur J Pharmacol; 1972 Jul; 19(1):112-4. PubMed ID: 4538041
    [No Abstract]   [Full Text] [Related]  

  • 14. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin.
    van Praag HM; Korf J; Lequin RM
    Psychopharmacol Commun; 1976; 2(5-6):369-78. PubMed ID: 1088302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turnover of central biogenic amines in two-kidney, one-clip renal hypertensive rats.
    Chen CS; Shum AY; Hsu SC; Chen CF
    Neurosci Lett; 1986 Aug; 69(2):166-71. PubMed ID: 3093935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral aromatic L-amino acids decarboxylase inhibitor in Parkinsonism. I. Effect on O-methylated metabolites of L-dopa-2- 14 C.
    Messiha FS; Hsu TH; Bianchine JR
    J Clin Invest; 1972 Feb; 51(2):452-5. PubMed ID: 5009125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain.
    Kehr W; Carlsson A; Lindqvist M
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 274(3):273-80. PubMed ID: 4262782
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of monoamine metabolism in the central nervous system.
    Carlsson A; Kehr W; Lindqvist M; Magnusson T; Atack CV
    Pharmacol Rev; 1972 Jun; 24(2):371-84. PubMed ID: 4564607
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro and in vivo effects of alpha-acetylenic DOPA and alpha-vinyl DOPA on aromatic L-amino acid decarboxylase.
    Ribéreau-Gayon G; Danzin C; Palfreyman MG; Aubry M; Wagner J; Metcalf BW; Jung MJ
    Biochem Pharmacol; 1979 Apr; 28(8):1331-5. PubMed ID: 312645
    [No Abstract]   [Full Text] [Related]  

  • 20. Regional gamma-aminobutyric acid levels in rat brain determined after microwave fixation.
    Balcom GJ; Lenox RH; Meyerhoff JL
    J Neurochem; 1975 Apr; 24(4):609-13. PubMed ID: 1123612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.